SecBot SecBot
SECBOTREPLAY Home › Report › STOK

STOK · Seven open-market share sales by four insiders at Stoke Therapeutics…

Stoke Therapeutics, Inc. · CLUSTER filed Mar 12, 2026 at 20:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 12, 2026 at 20:00 ET

Seven open-market share sales by four insiders at Stoke Therapeutics over the past week, including the CFO, Chief Medical Officer, General Counsel, and Chief Patient Officer, totaled approximately $772,200 in proceeds. The transactions include both routine sales and derivative exercises, with the majority of economic activity representing open-market selling.

  • CFO (Leggett Thomas) sold $67,980 worth of shares in open-market transaction
  • Chief Medical Officer (Ticho Barry) sold $234,647 in shares and exercised derivatives for 2,730 shares (non-cash value of $2,989)
  • General Counsel (Allan Jonathan) sold $424,439 in shares across two days
  • Total open-market sales by insiders: $772,207

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access